Accessibility Menu
Surgery Partners logo

Surgery Partners(NASDAQ) SGRY

Market Cap$2.01BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2015)-16%
5 Year-72%
1 Year-30%
1 Month-7%
$15.44
-2.93%
-0.47Today
After hours$15.38-$0.05 (-0.36%)
Surgery Partners last closing stock price
MetricPriceDate
Last closeUSD 15.402026-07-31
Surgery Partners stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.1%USD 15.732026-07-24
1 month-7.23%USD 16.602026-07-01
3 month+7.92%USD 14.272026-05-01
Year to date-0.32%USD 15.452025-12-31
1 year-29.84%USD 21.952025-07-31
3 year-58.31%USD 36.942023-08-01
5 year-71.77%USD 54.562021-07-30
Since inception-16.44%USD 18.432015-10-02

Surgery Partners Financials at a Glance

Market Cap

$2.01BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$3.34B

Net Income (TTM)

-$76.10M

EPS (TTM)

-$0.60

P/E Ratio

-25.88

Dividend

$0.00

Beta (Volatility)

1.52 (High)

Price

$15.44

Volume

1,138,180.972

Open

$15.90

Previous Close

$15.40

Daily Range

$15.38 - $16.02

52-Week Range

$11.41 - $24.10

Estimated Earnings Date

Aug 10, 2026

SGRY: Motley Fool Moneyball Superscore

46

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Surgery Partners

Surgery Partners runs a national network of outpatient surgical centers. The company helps people get surgeries without staying overnight. These centers provide a cheaper alternative to traditional hospitals.

Where Your Surgery Happens

  • Surgical Facilities: Centers providing non-emergency procedures like bone and eye care; generates nearly all revenue.
  • Ambulatory Surgery Centers: Short-stay facilities where patients receive surgery and return home the same day.
  • Surgical Hospitals: Small hospitals focused on elective procedures with short recovery times.
  • Ancillary Services: Support options like pharmacy, medical imaging, and labs at surgical sites.

Growing Beyond Hospitals

  • Expanded the network to 176 operational surgical facilities by December 31, 2025.
  • Increased reach to over 200 total locations in 30 states by the end of 2025.
  • Established strategic relationships with health systems to enhance its outpatient surgery footprint.

What Makes Them Different

The company uses a partnership model where local doctors often own a share of their surgical facilities. This strategy helps the business attract top doctors and keep them focused on providing high-quality outpatient care.

The Hard Numbers

  • Revenue reached $885 million in Q4 2025, up 2.4% from $864.4 million in Q4 2024.
  • Net loss reached $15 million in Q4 2025, which improved from $108.5 million in Q4 2024.
  • Free cash flow reached $90.6 million in Q4 2025, up 1.7% from $89.1 million in Q4 2024.
  • Operating income was $110.2 million in Q4 2025, down 13.3% from $127.1 million in Q4 2024.

The Bottom Line

Surgery Partners has successfully shifted toward a model focused on efficient, outpatient surgical care. Its network of centers provides a lower-cost alternative to large hospitals across the United States.

AI Generated • Apr 29, 2026

Industry

Healthcare Providers and Services

Employees

16,000

CEO

J. Eric Evans, MBA

Headquarters

Brentwood, TN 37027, US

SGRY Financials

Key Financial Metrics (TTM)

Gross Margin

21.68%

Operating Margin

12.26%

Net Income Margin

-2.28%

Return on Equity

-4.43%

Return on Capital

6.79%

Return on Assets

-0.95%

Earnings Yield

-3.86%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.01BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

130.79M

Volume

1.14M

Avg. Volume

1.54M

Financials (TTM)

Gross Profit

$724.80M

Operating Income

$410.00M

EBITDA

$958.20M

Operating Cash Flow

$280.00M

Capital Expenditure

-$72.00M

Free Cash Flow

$208.00M

Cash & ST Invst.

$182.30M

Total Debt

$4.03B

Surgery Partners Performance Analysis

Surgery Partners annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 2,539,300,00014.1%
20232023-12-31USD 2,743,300,0008.0%
20242024-12-31USD 3,114,300,00013.5%
20252025-12-31USD 3,308,700,0006.2%
Surgery Partners sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-306.5%
Q32025-09-30-0.6%
Q42025-12-317.7%
Q12026-03-31-8.4%
Surgery Partners annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.59-47.0%
20232023-12-31USD -0.09-84.1%
20242024-12-31USD -1.331307.4%
20252025-12-31USD -0.61-54.1%
Surgery Partners sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3093.4%
Q32025-09-30-813.7%
Q42025-12-3138.9%
Q12026-03-31-154.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$810.90M

+4.5%

Gross Profit

$121.70M

-24.8%

Gross Margin

15.01%

N/A

Market Cap

$2.01BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$125.88K

N/A

Employees

16,000

N/A

Net Income

-$35.90M

+4.8%

EBITDA

$105.70M

+7.6%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$182.30M

-20.5%

Total Debt

$4.03B

+3.9%

Accounts Receivable

$603.40M

+5.7%

Inventory

$100.50M

+14.1%

Long Term Debt

$3.89B

+4.1%

Short Term Debt

$142.60M

-0.6%

Return on Assets

-0.95%

N/A

Return on Invested Capital

5.50%

N/A

Free Cash Flow

-$4.30M

+74.3%

Operating Cash Flow

$11.70M

+95.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ZLABZai Lab Limited
$18.27+0.33%
HTFLHeartflow, Inc. Common Stock
$25.23-2.32%
ARDTArdent Health Inc.
$10.67-0.56%
ATECAlphatec Holdings, Inc.
$9.52-1.45%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About SGRY

What is the current price of Surgery Partners?

Surgery Partners is trading at $15.40 per share.

What is the 52-week range for Surgery Partners?

Over the past 52 weeks, Surgery Partners has traded between $11.41 and $24.10.

How much debt does Surgery Partners have?

As of the most recent reporting period, Surgery Partners reported total debt of $4.03B.

How much cash does Surgery Partners have on hand?

Surgery Partners reported $182.30M in cash and cash equivalents in its most recent financial results.

What is Surgery Partners’s dividend yield?

Surgery Partners does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.